Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

NCT07538609 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT07538609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07538609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 7, 2026
Completion date
May 31, 2031
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vein thrombosis, venous disease, venous leg ulcer, venous occlusion, venous stasis, venous stenosis, venous thromboses, venous ulcer